Femtech’s Rise in Health & Financial Services

Cassandra Duchan Saucedo
2 min readMay 20, 2021

--

Investment Thesis: Women have been neglected from major industries like healthcare and financial services, hence femtech products and services built for women’s needs inherently disrupt and create markets.

Image Courtesy of Usbek & Rica.

Context

Given women’s historical exclusion from many areas, the emerging femtech space within healthcare and financial services offers product innovation that draws from a previously untapped market.

  • The US has notoriously high health prices and low healthcare accessibility for women.
  • Overall healthcare spending in the US is around $11.9 trillion or about $11,200 per person.
  • Additionally, women face a Pink Tax in relation to their healthcare costs that impacts medically necessary products related to menstruation.
  • Similarly, financial products are not built for women.
  • Women tend to make less money, have fewer savings, and live longer lives; hence, products that do not incorporate these factors will fail women.
  • Given that women make up 51% of the population, companies democratize products and services built for women’s specific problems are at a huge market advantage and create social good.

Market Overview

Interesting Companies with Venture Returns

  • Modern Fertility, D2C fertility related products including home fertility tests, ovulation tests, and pregnancy tests. $60M valuation, 50 employees, $21M raised, Series A.
  • Aunt Flow, B2C & B2B manufacturer of menstrual products with an emphasis on affordable access. $330K valuation, 16 employees, $1.5M raised, Seed.
  • Ellevest, Roboadvisor created for women to assist them in achieving financial goals like retirement and building a business. $187M valuation, 103 employees, $81.5M raised, Series A2.
  • Snowball Wealth, Personal wealth platform to help women tackle their consumer and student debt. Undisclosed deal and company information.

--

--

No responses yet